EEG Biomarker for Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that accounts for nearly 70% of the more than 50 million dementia cases estimated worldwide. There is no cure for AD. Currently, AD diagnosis is carried out using neuropsychological tests, neuroimaging scans, and laboratory tests. In the early...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/73370 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: EEG Biomarker for Alzheimer’s Disease
- Seizures in Adult with Neurofibromatosis Type 1
- The Epidemiology of Vascular Dementia
- Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
- Oxidative Stress in Alzheimer’s Disease: Pathogenesis, Biomarkers and Therapy
- MicroRNAs as Future Treatment Tools and Diagnostic Biomarkers in Alzheimer’s Disease
- Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation